Our results were consistent with other studies that reported that TNF-α, FFAs, and ROS activated JNK and promoted initiation and progression of insulin resistance and the development of NAFLD [62,63]. The gene discussed is MAPK8; the disease is metabolic dysfunction-associated steatotic liver disease.